11 Best Pharma and Biotech Stocks to Buy According to Jim Simons’ Euclidean Capital
In this article, we will discuss the 11 best pharma and biotech stocks to buy according to Jim Simons' Euclidean Capital.
Vir Biotechnology Inc. (VIR)
Get Email Alerts Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 317,150 | $14,995 | +686% | 0% |
| 2. | D E Shaw D. E. Shaw | 219,228 | $10,365 | +89% | 0% |
| 3. | Renaissance Technologies Jim Simons | 80,102 | $3,787 | 0% | |
| 4. | 71,000 | $3,357 | -5% | 0% | |
| 5. | 54,900 | $2,596 | -41% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.00 | 1,000,000 | Director | 1,000,000 | 2019-10-16 | Filing | |
| $20.00 | 1,000,000 | Large Shareholder, Director | 1,000,000 | 2019-10-16 | Filing | |
| $20.00 | 1,000,000 | Large Shareholder | 1,000,000 | 2019-10-16 | Filing | |
| $20.00 | 500,000 | Large Shareholder | 5,499,999 | 2019-10-16 | Filing | |
| $20.00 | 1,000,000 | Other | 3,666,666 | 2019-10-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $39.65 | 4,000 | Officer | 100,277 | 2021-10-20 | Filing | |
| $38.87 | 1,375 | Officer | 107,700 | 2021-10-19 | Filing | |
| $39.91 | 8,503 | Director | 1,581,440 | 2021-10-19 | Filing | |
| $39.12 | 6,671 | Director | 1,589,943 | 2021-10-19 | Filing | |
| $34.56 | 5,000 | Officer | 104,277 | 2021-10-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 3,899,692 | $169,715 | 0.09% | |
| 2. | 42,667 | $1,857 | 0.16% | |
| 3. | 38,550 | $1,678 | 0.14% | |
| 4. | 38,100 | $1,644 | 0% | |
| 5. | 37,132 | $1,616 | 0.44% |
News See All
Is Vir Biotechnology (VIR) A Good Stock To Buy Now?
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions as of September...
Vir Biotechnology, Inc. (VIR): Hedge Funds Aren’t Enthusiastic
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Trumpdesivir: Operation Warp Speed, “Engage.”
The COVID-19 vaccine race officially goes into high gear with the announcement of USA’s plan to test the 6-odd top vaccine candidates across upwards of 150,000 volunteers (min.
Stocks Amid COVID-19 Outbreak: Winners So Far in the Health Industry
At its worst on March 23rd, Dow Jones and the S&P declined by around 37% and 34%. At the time, those kinds of numbers represented a loss of a 3-year gain since Trump’s election in November of 2016.
Billionaire Hedge Funds
